Parker C. Wilson, MD, PhD
Assistant Professor of Pathology and Laboratory MedicinePerelman School of Medicine at the University of Pennsylvania
Contact Information
Email: parker.wilson@pennmedicine.upenn.edu
Specialty Division
Anatomic Pathology, Cancer and Immunobiology
Education
BS (Engineering with a Concentration in Computer Science), Johns Hopkins University, 2005
MD, PhD (Molecular and Cellular Biology and Pathobiology), Medical University of South Carolina, 2013
Specialty Certification
American Board of Pathology - Anatomic and Clinical Pathology, 2017
American Board of Pathology - Molecular Genetic Pathology, 2021
Postgraduate Training
Residency, Anatomic and Clinical Pathology, Yale New Haven Hospital, 2013-2017
Clinical Fellowship, Renal and Genitourinary Pathology, Yale New Haven Hospital, 2017-2018
Clinical Fellowship, Molecular Genetic Pathology, Washington University School of Medicine, St. Louis, MO, 2018-2019
Awards and Honors
Harvard-MIT National Science Foundation Research Fellow, 2004
Ruth L. Kirschstein Individual Predoctoral National Research Service Award (F30), 2011-2012
Chairman’s Challenge Grant for Mentored Research in Residency, 2014-2017
American Society of Nephrology Kidney STAR Travel Grant, 2015
Kidney Precision Medicine Project Travel Grant, Washington University School of Medicine, 2018
Best AP Oral Abstract Trainee Research Day, Washington University School of Medicine, 2019
Diabetes Research Center Symposium Best Oral Abstract in Basic Science Category, Washington University School of Medicine, 2020
NIH NIDDK K08 Career Development Award, 2022-2026
Young Physician Scientist Award - American Society of Clinical Investigation, 2023
Memberships and Professional Organizations
United States and Canadian Academy of Pathology, 2013 - Present
American Society of Nephrology, 2015 - Present
Renal Pathology Society, 2018 - Present
Association for Molecular Pathology, 2019 - Present
ClinGen Glomerulopathy and Cystic Kidney Disease Gene Curation Expert Panel, 2021 - 2023
Grant Reviewer - NIH - NIDDK - Diacomp, 2022 - 2022
Grant Reviewer - NIH - Innovative Science Accelerator, 2023 - Present
Web Links
Selected Publications
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO 3rd, Wigley FM, Wilson PC, DiRenzo DD, Shah AA, Semin Arthritis Rheum, 2024, PMID:38733668
Predicting proximal tubule failed repair drivers through regularized regression analysis of single cell multiomic sequencing
Ledru N, Wilson PC, Muto Y, Yoshimura Y, Wu H, Li D, Asthana A, Tullius SG, Waikar SS, Orlando G, Humphreys BD, Nat Communications, 2024, PMID:38347009
Mosaic loss of Y chromosome is associated with aging and epithelial injury in chronic kidney disease
Wilson PC, Verma A, Yoshimura Y, Muto Y, Li H, Malvin NP, Dixon EE, Humphreys BD, Genome Biology, 2024
Washington Manual of Transplant Pathology
Tarek Alhamad (Editor), Wolters Kluwer, 2023
Mapping genomic regulation of kidney disease and traits through high-resolution and interpretable eQTLs
Han SK, McNulty MT, Benway CJ, Wen P, Greenberg A, Onuchic-Whitford AC; Nephrotic Syndrome Study Network (NEPTUNE); Jang D, Flannick J, Burtt NP, Wilson PC, Humphreys BD, Wen X, Han Z, Lee D, Sampson MG., Nat Commun 14(): 2229, 2023, PMID:37076491
Quality assessment and refinement of chromatin accessibility data using a sequence-based predictive model
Han SK, Muto Y, Wilson PC, Humphreys BD, Sampson MG, Chakravarti A, Lee D., Proc Natl Acad Sci U S A 119(): e2212810119, 2022, PMID:36508674
Concordance in Breast Cancer Grading by Artificial Intelligence on Whole Slide Images Compares With a Multi-Institutional Cohort of Breast Pathologists
Mantrala S, Ginter PS, Mitkari A, Joshi S, Prabhala H, Ramachandra V, Kini L, Idress R, D'Alfonso TM, Fineberg S, Jaffer S, Sattar AK, Chagpar AB, Wilson P, Singh K, Harigopal M, Koka D., Arch Pathol Lab Med 146(): 1369-1377, 2022, PMID:35271701
Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis
Muto Y, Dixon EE, Yoshimura Y, Wu H, Omachi K, Ledru N, Wilson PC, King AJ, Eric Olson N, Gunawan MG, Kuo JJ, Cox JH, Miner JH, Seliger SL, Woodward OM, Welling PA, Watnick TJ, Humphreys BD., Nat Commun 13(): 6497, 2022, PMID:36310237
Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression
Wilson PC, Muto Y, Wu H, Karihaloo A, Waikar SS, Humphreys BD., Nat Commun 13(): 5253, 2022, PMID:36068241
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
Kobayashi H, Looker HC, Satake E, D'Addio F, Wilson JM, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Badger HS, Petrazzuolo A, Corradi D, Galecki A, Wilson PC, Najafian B, Mauer M, Niewczas MA, Doria A, Humphreys BD, Duffin KL, Fiorina P, Nelson RG, Krolewski AS., Sci Transl Med 14(): eabj2109, 2022, PMID:35947673
